Kolon TissueGene Inc
950160
Company Profile
Business description
Kolon TissueGene Inc is a biopharmaceutical company that develops regenerative therapies for the treatment of various orthopedic disorders. It is developing four product candidates, TG-C, TG-B, TG-D and TG-N for regeneration of cartilage, bone, disc and nerve.
Contact
9713 Key West Avenue
Suite 300
RockvilleMD20850
USAT: +1 301 921-6000
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
51
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,117.50 | 64.30 | 0.80% |
| CAC 40 | 7,790.71 | 125.37 | -1.58% |
| DAX 40 | 22,163.49 | 298.03 | -1.33% |
| Dow JONES (US) | 42,001.76 | 417.86 | 1.00% |
| FTSE 100 | 8,582.81 | 76.04 | -0.88% |
| HKSE | 23,363.96 | 244.38 | 1.06% |
| NASDAQ | 17,299.29 | 23.70 | -0.14% |
| Nikkei 225 | 35,630.95 | 13.39 | 0.04% |
| NZX 50 Index | 12,312.60 | 42.60 | 0.35% |
| S&P 500 | 5,611.85 | 30.91 | 0.55% |
| S&P/ASX 200 | 7,916.00 | 72.60 | 0.93% |
| SSE Composite Index | 3,355.31 | 19.56 | 0.59% |